Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Artificial Intelligence (AI) in Cancer
... covers market projections through 2029 and presents a competitive environment and product analysis. The report provides market estimates and forecasts based on application, cancer type and region. By application type, the market is segmented into ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Cell and Gene Therapy Tools, and Reagents: Global Markets
... end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. ... Read More
-
Specialty Excipients for Parenteral Pharmaceuticals Market - A Global and Regional Analysis: Focus on Application, End User, and Country - Analysis and Forecast, 2024-2034
... excipients for parenteral pharmaceuticals market is witnessing significant growth, driven by increasing demand for advanced drug delivery systems, particularly for biologics and complex formulations. Specialty excipients play a crucial role in parenteral formulations by ensuring ... Read More
-
Global Lentiviral Vector In Gene Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The global pharmaceutical market is 1475 billion USD in ... Read More
-
Global Gene Therapy Medicinal Products (GTMP) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The global pharmaceutical market is 1475 billion USD in ... Read More
-
Global Cellular and Gene Therapy CDMO Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... provides a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various ... Read More
-
Global Gene Therapy Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. According to our research, the global market for medical devices is estimated at ... Read More
-
Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Growth (Status and Outlook) 2024-2030
... 750.3 million in 2023. With growing demand in downstream market, the Adeno-Associated Virus (AAV) Vector-Based Gene Therapy is forecast to a readjusted size of US$ 1098.9 million by 2030 with a CAGR of 5.6% during ... Read More
-
Global Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Gene Therapy Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Cell and Gene Therapy CDMO Market Forecasts to 2030 – Global Analysis By Type of Therapy (Cell Therapy, Gene Therapy and Other Type of Therapies), Service Type, Technology, End User and By Geography
... Stratistics MRC, the Global Cell and Gene Therapy CDMO Market is accounted for $6.48 billion in 2024 and is expected to reach $31.14 billion by 2030 growing at a CAGR of 29.9% during the forecast ... Read More
-
Primary Immunodeficiency Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Others), By Treatment (Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem Cell/Bone Marrow Transplantation, Gene Therapy, Others), By Region and Competition, 2019-2029F
... Gene Therapy, Others), By Region and Competition, 2019-2029F Global Primary Immunodeficiency Disorders Market was valued at USD 7.03 Billion in 2023 and is expected to reach USD 9.88 Billion by 2029 with a CAGR of ... Read More
-
South & Central America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The South & Central America bioprocessing market was valued at US$ 892.42 million in ... Read More
-
Middle East & Africa Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Middle East & Africa bioprocessing market was valued at US$ 314.37 million in ... Read More
-
Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected ... Read More
-
North America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The North America bioprocessing market was valued at US$ 12,440.60 million in 2023 and is expected ... Read More
-
Europe Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Europe bioprocessing market was valued at US$ 6,216.50 million in 2023 and is expected to reach ... Read More
-
Global Cell and Gene Therapy Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030
... at US$ million in 2023. With growing demand in downstream market, the Cell and Gene Therapy Drug Delivery Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
Global Cell and Gene Therapy Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Cell and Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Viral Vectors Gene Therapy Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Viral Vectors Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Non-viral Vectors Gene Therapy Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Non-viral Vectors Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Cell Therapy Market Analysis and Forecast to 2033: By Cell Type (Stem, T-Cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), Therapeutic Area (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Dermatological Disorders, Others), Application (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-Based Assays, Others), End-User (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), Stage Of Development (Preclinical, Phase I, Phase II, Phase III, Commercialized), Technology (Viral Vector-Based, Non-Viral Vector-Based, Gene Editing Technologies), Mode Of Delivery (Intravenous, Intramuscular, Subcutaneous, Others), and Region
... Dermatological Disorders, Others), Application (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-Based Assays, Others), End-User (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), Stage Of Development (Preclinical, Phase I, Phase II, Phase III, Commercialized), Technology ... Read More
-
Vaccine Contract Manufacturing Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... contract manufacturing market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global vaccine contract manufacturing market by segmenting ... Read More
-
Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share, Trends, Industry Analysis Report – By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, and Others), By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2024–2032
... and By Region; Segment Forecast, 2024–2032 The cell & gene therapy bioanalytical testing services market size is expected to reach USD 950.06 million by 2032, according to a new study by Polaris Market Research. The ... Read More
-
Adeno-Associated Virus (AAV) CDMO Market Size & Share Analysis - Growth, Trends & Forecasts (2024-2029)
... 1.40 billion by 2029, growing at a CAGR of 20.86% during the forecast period (2024-2029). The key factors driving the growth of the adeno-associated virus CDMO market include the increasing use of gene therapy, advancements ... Read More
Research Assistance
